Antibodies specific for DKK-1 and their uses
The present invention provides antibodies and fragments thereof that bind to Dkk-1 and, in particular, to humanized antibodies and fragments thereof that bind to Dkk-1 and, even more particularly to fully humanized antibodies and immunologically functional fragments that bind to Dkk-1. Also provided are antibodies and fragments thereof which compete with the binding of an anti-mouse Dkk-1 monoclonal antibody for binding to Dkk-1+ cells. Also provided are nucleic acids encoding anti-Dkk-1 antibodies or fragments thereof, as well as expression vectors and host cells incorporating these nucleic acids for the recombinant expression of anti-Dkk-1 antibodies and fragments thereof. Also provided are methods of preparing the antibodies and fragments thereof of the invention. Also provided are bone anabolic agents. Pharmaceutical compositions comprising the antibodies or fragments thereof of the invention are also provided. Further provided are methods of treating diseases, conditions and disorders, such as bone disorders, which result in a loss of bone. Methods of treating or preventing a loss of bone mass, methods of inducing increased bone mass, and methods of inducing Wnt activity are also provided.
Pfizer Inc. Rinat Neuroscience Corp.
A C A A C C C C C C A C C A A A C C A A A
A61P C07K A61P A61P C12N C07K C07K C07K C07K C12N A61P C07K C07K A61P A61K A61P C07K C07K A61P A61P A61P
inventional additional inventional inventional inventional additional inventional additional additional inventional inventional additional additional inventional additional inventional additional inventional inventional inventional inventional
Mei Jaume Vishwas Madhav Donna Marie
Li Pons Paralkar Stone